Search Results - "Ben Mamou, M."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    The state of measles and rubella in the WHO European Region, 2013 by Muscat, M., Shefer, A., Mamou, M. Ben, Spataru, R., Jankovic, D., Deshevoy, S., Butler, R., Pfeifer, D.

    Published in Clinical microbiology and infection (01-05-2014)
    “…Measles and rubella persist in the World Health Organization European Region despite long-standing and widespread use of vaccines against them. Our aim was to…”
    Get full text
    Journal Article
  2. 2

    Measles and rubella seroprevalence among adults in Georgia in 2015: helping guide the elimination efforts by Khetsuriani, N, Chitadze, N, Russell, S, Ben Mamou, M

    Published in Epidemiology and infection (01-01-2019)
    “…A large-scale measles outbreak (11 495 reported cases, 60% aged ≥15 years) occurred in Georgia during 2013-2015. A nationwide, multistage, stratified cluster…”
    Get full text
    Journal Article
  3. 3

    Long-term transmission of measles virus in Central and continental Western Europe by Santibanez, S., Hübschen, J. M., Muller, C. P., Freymuth, F., Mosquera, M. M., Mamou, M. Ben, Mulders, M. N., Brown, K. E., Myers, R., Mankertz, A.

    Published in Virus genes (01-02-2015)
    “…The World Health Organization (WHO) has adopted an elimination goal for measles and rubella, which is supposed to be met in the WHO European Region (EUR) by…”
    Get full text
    Journal Article
  4. 4

    Measles and rubella elimination in the WHO Region for Europe: progress and challenges by O'Connor, P., Jankovic, D., Muscat, M., Ben-Mamou, M., Reef, S., Papania, M., Singh, S., Kaloumenos, T., Butler, R., Datta, S.

    Published in Clinical microbiology and infection (01-08-2017)
    “…Globally measles remains one of the leading causes of death among young children even though a safe and cost-effective vaccine is available. The World Health…”
    Get full text
    Journal Article
  5. 5

    Molecular surveillance of measles and rubella in the WHO European Region: new challenges in the elimination phase by Santibanez, S., Hübschen, J.M., Ben Mamou, M.C., Muscat, M., Brown, K.E., Myers, R., Donoso Mantke, O., Zeichhardt, H., Brockmann, D., Shulga, S.V., Muller, C.P., O'Connor, P.M., Mulders, M.N., Mankertz, A.

    Published in Clinical microbiology and infection (01-08-2017)
    “…The WHO European Region (EUR) has adopted the goal of eliminating measles and rubella but individual countries perform differently in achieving this goal…”
    Get full text
    Journal Article
  6. 6

    Challenges of measles and rubella laboratory diagnostic in the era of elimination by Hübschen, J.M., Bork, S.M., Brown, K.E., Mankertz, A., Santibanez, S., Ben Mamou, M., Mulders, M.N., Muller, C.P.

    Published in Clinical microbiology and infection (01-08-2017)
    “…The Member States of the WHO European Region adopted the goal of measles and rubella elimination more than 10 years ago, but so far only 21 of 53 countries…”
    Get full text
    Journal Article
  7. 7

    IMPROVEMENT OF THE QUALITY CONTROL OF ELISA TESTING FOR THE LABORATORY CONFIRMATION OF MEASLES AND RUBELLA INFECTIONS AT THE STAGE OF THE MEASLES/ RUBELLA ELIMINATION PROGRAM by Mamaeva, T. A., Zheleznova, N. V., Nаumova, M. A., Chekhlyaeva, T. S., Vorobeychikovc, E. V., Ben Mamou, M., Aleshkin, V. A.

    Published in Infekt͡s︡ii͡a︡ i immunitet (01-01-2017)
    “…To estimate ELISA serological studies results of IgM and IgG specific Measles and Rubella Viruses (MRV) antibodies detection the “in-house” laboratory controls…”
    Get full text
    Journal Article
  8. 8

    Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy by Jlizi, A, Ben Ammar El Gaaied, A, Slim, A, Tebourski, F, Ben Mamou, M, Ben Chaabane, T, Letaief-Omezzine, A, Chakroun, M, Garbouj, M, Ben Rejeb, S

    Published in Archives of virology (2008)
    “…Three years after the introduction of antiretroviral therapy (ART) in Tunisia (North Africa), we aimed to determine the prevalence of drug resistance mutations…”
    Get full text
    Journal Article
  9. 9

    Use of combined detection of hepatitis C virus core antigen and antibodies to reduce the serological window-phase by Hmaïed, F, Ben Mamou, M, Arrouji, Z, Slim, A, Ben Redjeb, S

    Published in Pathologie biologie (Paris) (01-03-2007)
    “…In this study, we aimed at evaluating the performances of a combined assay for the detection of hepatitis C virus core antigen and antibodies and comparing…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Intérêt du dépistage combiné de l'antigène de capside et des anticorps du virus de l'hépatite C dans la réduction de la fenêtre sérologique by Hmaïed, F., Ben Mamou, M., Arrouji, Z., Slim, A., Ben Redjeb, S.

    Published in Pathologie biologie (Paris) (01-03-2007)
    “…Nous nous proposons dans cette étude d'évaluer l'intérêt d'utilisation d'un test de dépistage combiné des anticorps anti-VHC et de l'antigène de capside, et de…”
    Get full text
    Journal Article
  12. 12

    Hepatitis C virus infection among dialysis patients in Tunisia: Incidence and molecular evidence for nosocomial transmission by Hmaied, Fatma, Ben Mamou, Myriam, Saune-Sandres, Karine, Rostaing, Lionel, Slim, Amine, Arrouji, Zakia, Ben Redjeb, Saïda, Izopet, Jacques

    Published in Journal of medical virology (01-02-2006)
    “…In order to study the incidence of hepatitis C virus (HCV) infection in Tunisian haemodialysis patients and detect its nosocomial transmission, 395 patients…”
    Get full text
    Journal Article
  13. 13
  14. 14